Weekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin episode artwork

EPISODE · Aug 7, 2024 · 6 MIN

Weekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin

from Eyewire News: The Podcast · host Eyewire News

Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin • Wearable Aid with AI-Powered Visual Assistant is Unveiled • ASCRS Business of Refractive Cataract Surgery Summit Launched Learn more about your ad choices. Visit megaphone.fm/adchoices

Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin • Wearable Aid with AI-Powered Visual Assistant is Unveiled • ASCRS Business of Refractive Cataract Surgery Summit Launched Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Weekly Headlines: Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin

0:00 6:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 6 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on August 7, 2024.

What is this episode about?

Two Phase 3 Trials for Dry and Wet AMD Drug Candidates Begin • Wearable Aid with AI-Powered Visual Assistant is Unveiled • ASCRS Business of Refractive Cataract Surgery Summit Launched Learn more about your ad choices. Visit megaphone.fm/adchoices

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!